Adolore BioTherapeutics Outlines Strategy for its Next Generation, Disease-Modifying, Non-Opioid Analgesic Gene Therapies for the Treatment of Chronic Pain
Crwe World,
Development program for the treatment of osteoarthritis (OA) chronic knee pain is fully funded through the first-in-human…